Partnerships for African Vaccine Manufacturing (PAVM) Framework for Action

Foreword
It gives me great pleasure to present the Framework for Action (FFA) that the Partnerships for African Vaccine Manufacturing (PAVM) has prepared under the supervision of the African Centers for Disease Control and Prevention (Africa CDC). The Framework for Action sets forth the key diagnostic findings on the current vaccine manufacturing environment in Africa and recommends eight bold programs to unlock Africa’s potential to grow and scale vaccine development and manufacturing over the next two decades.
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expand the local manufacture of vaccines, diagnostics, and therapeutics. Presently, less than one percent of vaccines administered on the continent are manufactured locally. This places a great burden on the health systems of African countries and reduces their ability to respond to pandemics and other health crises.

The Framework for Action answers the call made by the African Union Commission and the African Centers for Disease Control and Prevention at a summit in April 2021 to develop a framework that will enable Africa to manufacture 60 percent of its vaccine needs locally by 2040. The bold programs it outlines will see Africa become more self-reliant as it addresses its vaccination needs.